After trying antihistamines, cut to a first-of-its-kind* pill for CSU1
RHAPSIDO® (remibrutinib) is not an antihistamine or injection. It’s an oral therapy that is indicated for the treatment of chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1 antihistamine treatment. It is not indicated for other forms of urticaria.1
*Bruton's tyrosine kinase inhibitor indicated for CSU.1
Oral dosing
RHAPSIDO is an oral tablet that is taken twice daily.1 It’s recommended that one tablet be taken in the morning and one at night.
The recommended dose of RHAPSIDO is 25 mg taken orally twice daily. RHAPSIDO may be taken with or without food. The tablets should be swallowed whole with water, and should not be split, crushed, or chewed. If a dose of RHAPSIDO is missed, it should be skipped, and the next dose should be taken at its regularly scheduled time. Your patients should not take extra doses to make up for a missed dose or doses.1
Interrupt treatment with RHAPSIDO for 3 to 7 days pre- and post-surgery depending upon the type of surgery and the risk of bleeding.1
See Prescribing Information for full dosing details.